Thanh bên bài viết

PDF (English)
Đã xuất bản: 2026-06-09
Số lượt xem tóm tắt: 0
Số lượt xem PDF (English): 0
DOI: https://doi.org/10.52852/tcncyh.v202i5E18.5214
Số xuất bản
Tập 202 Số 5E18 (2026)
Chuyên mục
Các bài báo
Cách trích dẫn
Thang, P. X., Minh, N. D., Hoi, D. V., Dat, N. T., Thu, N., Hung, H. T., Chi, N. V., Quan, N. H., & Tuan, N. A. (2026). Clinical and hemodynamic characteristics of cardiogenic shock complicating acute myocardial infarction. Tạp Chí Nghiên cứu Y học, 202(5E18), 276-284. https://doi.org/10.52852/tcncyh.v202i5E18.5214

Clinical and hemodynamic characteristics of cardiogenic shock complicating acute myocardial infarction

Pham Xuan Thang, Nguyen Duy Minh, Dang Van Hoi, Nguyen Tien Dat, Nguyen Thu, Ha Tran Hung, Nguyen Van Chi, Nguyen Huu Quan, Nguyen Anh Tuan

Nội dung chính của bài viết

Tóm tắt

Among 84 patients with cardiogenic shock classified as Society for Cardiovascular Angiography and Interventions (SCAI) stage D–E, the in-hospital mortality rate was 29.8%. Mixed venous oxygen saturation (SvO2) was associated with in-hospital mortality, with an optimal cutoff value of ≤55%. Patients with a cardiac power output (CPO) <0.535 W exhibited higher in-hospital mortality. These findings suggest that SvO2 and CPO may provide additional value for early risk stratification among patients with cardiogenic shock complicating acute myocardial infarction, even within the same SCAI stage.

Chi tiết bài viết

Từ khóa

Cardiogenic shock, cardiac power output, hemodynamics, microcirculation, mixed venous oxygen saturation

Tài liệu tham khảo

1. Waksman R, Pahuja M, van Diepen S, et al. Standardized definitions for cardiogenic shock research and mechanical circulatory support devices: Scientific Expert Panel from the Shock Academic Research Consortium (SHARC). Circulation. 2023; 148(14): 1113-1126. doi:10.1161/CIRCULATIONAHA.123.064527.
2. Sinha SS, Morrow DA, Kapur NK, et al. 2025 concise clinical guidance: An ACC expert consensus statement on the evaluation and management of cardiogenic shock. J Am Coll Cardiol. 2025; 85(16): 1618-1641. doi:10.1016/j.jacc.2025.02.018.
3. Kapur NK, Kanwar M, Sinha SS, et al. Criteria for defining stages of cardiogenic shock severity. J Am Coll Cardiol. 2022; 80(3): 185-198. doi:10.1016/j.jacc.2022.04.049.
4. Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J. 2023; 44(38): 3720-3826. doi:10.1093/eurheartj/ehad191.
5. Thiele H, Zeymer U, Neumann FJ, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012; 367(14): 1287-1296. doi:10.1056/NEJMoa1208410.
6. Hernandez GA, Lemor A, Blumer V, et al. Trends in utilization and outcomes of pulmonary artery catheterization in heart failure with and without cardiogenic shock. J Card Fail. 2019; 25(5): 364-371. doi:10.1016/j.cardfail.2019.03.004.
7. Thiele H, Akin I, Sandri M, et al. PCI strategies in patients with acute myocardial infarction and cardiogenic shock. N Engl J Med. 2017; 377(25): 2419-2432. doi:10.1056/NEJMoa1710261.
8. Réa A, Mihajlovic V, Vishram-Nielsen JKK, et al. Pulmonary artery catheter usage and impact on mortality in patients with cardiogenic shock: Results from a Canadian single-centre registry. Can J Cardiol. 2024; 40(4): 664-673. doi:10.1016/j.cjca.2023.12.005.
9. Kadosh BS, Berg DD, Bohula EA, et al. Pulmonary artery catheter use and mortality in the cardiac intensive care unit. JACC Heart Fail. 2023; 11(8 Pt 1): 903-914. doi:10.1016/j.jchf.2023.04.007.
10. Ostadal P, Vondrakova D, Rokyta R, et al. Cardiac index, SvO2 or pCO2 gap may determine benefit from ECMO in cardiogenic shock: Post-hoc analysis of the multicenter, randomized ECMO-CS trial. Crit Care. 2025; 29(1): 303. doi:10.1186/s13054-025-05513-5.
11. Kosyakovsky LB, Earle WB, Wichern C, et al. Macrovascular hemodynamics and peripheral perfusion in cardiogenic shock: Exploring current targets and future directions. JACC Adv. 2025; 4(10 Pt 1): 101964. doi:10.1016/j.jacadv.2025.101964.